GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Makers Laboratories Ltd (BOM:506919) » Definitions » ROCE %

Makers Laboratories (BOM:506919) ROCE % : 0.45% (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Makers Laboratories ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Makers Laboratories's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.45%.


Makers Laboratories ROCE % Historical Data

The historical data trend for Makers Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Makers Laboratories ROCE % Chart

Makers Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.84 5.61 16.20 1.09 -1.58

Makers Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.47 -3.18 -1.71 -1.90 0.45

Makers Laboratories ROCE % Calculation

Makers Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=-19.631/( ( (1522.95 - 275.375) + (1612.558 - 371.728) )/ 2 )
=-19.631/( (1247.575+1240.83)/ 2 )
=-19.631/1244.2025
=-1.58 %

Makers Laboratories's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=5.532/( ( (0 - 0) + (1612.558 - 371.728) )/ 1 )
=5.532/( ( 0 + 1240.83 )/ 1 )
=5.532/1240.83
=0.45 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Makers Laboratories  (BOM:506919) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Makers Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of Makers Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Makers Laboratories (BOM:506919) Business Description

Traded in Other Exchanges
N/A
Address
54-D, Kandivli Industrial Estate, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti cough Range), and Exylin (Amoxycillin range) among others.

Makers Laboratories (BOM:506919) Headlines

No Headlines